List of Tables
Table 1. Global Anti-VEGF Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Anti-VEGF Injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Anti-VEGF Injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Anti-VEGF Injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Anti-VEGF Injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Anti-VEGF Injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Anti-VEGF Injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Anti-VEGF Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Anti-VEGF Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-VEGF Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-VEGF Injection, Product Type & Application
Table 12. Global Key Manufacturers of Anti-VEGF Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-VEGF Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-VEGF Injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-VEGF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Anti-VEGF Injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Anti-VEGF Injection Sales Market Share by Region (2020-2025)
Table 19. Global Anti-VEGF Injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Anti-VEGF Injection Sales Market Share by Region (2026-2031)
Table 21. Global Anti-VEGF Injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Anti-VEGF Injection Revenue Market Share by Region (2020-2025)
Table 23. Global Anti-VEGF Injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Anti-VEGF Injection Revenue Market Share by Region (2026-2031)
Table 25. North America Anti-VEGF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Anti-VEGF Injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Anti-VEGF Injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Anti-VEGF Injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Anti-VEGF Injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Anti-VEGF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Anti-VEGF Injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Anti-VEGF Injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Anti-VEGF Injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Anti-VEGF Injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Anti-VEGF Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Anti-VEGF Injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Anti-VEGF Injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Anti-VEGF Injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Anti-VEGF Injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti-VEGF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Anti-VEGF Injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Anti-VEGF Injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Anti-VEGF Injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-VEGF Injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Anti-VEGF Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Anti-VEGF Injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Anti-VEGF Injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Anti-VEGF Injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Anti-VEGF Injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Anti-VEGF Injection Sales (K Units) by Type (2020-2025)
Table 51. Global Anti-VEGF Injection Sales (K Units) by Type (2026-2031)
Table 52. Global Anti-VEGF Injection Sales Market Share by Type (2020-2025)
Table 53. Global Anti-VEGF Injection Sales Market Share by Type (2026-2031)
Table 54. Global Anti-VEGF Injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Anti-VEGF Injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Anti-VEGF Injection Revenue Market Share by Type (2020-2025)
Table 57. Global Anti-VEGF Injection Revenue Market Share by Type (2026-2031)
Table 58. Global Anti-VEGF Injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Anti-VEGF Injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Anti-VEGF Injection Sales (K Units) by Application (2020-2025)
Table 61. Global Anti-VEGF Injection Sales (K Units) by Application (2026-2031)
Table 62. Global Anti-VEGF Injection Sales Market Share by Application (2020-2025)
Table 63. Global Anti-VEGF Injection Sales Market Share by Application (2026-2031)
Table 64. Global Anti-VEGF Injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Anti-VEGF Injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Anti-VEGF Injection Revenue Market Share by Application (2020-2025)
Table 67. Global Anti-VEGF Injection Revenue Market Share by Application (2026-2031)
Table 68. Global Anti-VEGF Injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Anti-VEGF Injection Price (US$/Unit) by Application (2026-2031)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Roche Anti-VEGF Injection Product
Table 74. Roche Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Bayer Anti-VEGF Injection Product
Table 79. Bayer Recent Developments/Updates
Table 80. Genentech Company Information
Table 81. Genentech Description and Business Overview
Table 82. Genentech Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Genentech Anti-VEGF Injection Product
Table 84. Genentech Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Anti-VEGF Injection Product
Table 89. Novartis Recent Developments/Updates
Table 90. Coherus BioSciences Inc. Company Information
Table 91. Coherus BioSciences Inc. Description and Business Overview
Table 92. Coherus BioSciences Inc. Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Coherus BioSciences Inc. Anti-VEGF Injection Product
Table 94. Coherus BioSciences Inc. Recent Developments/Updates
Table 95. Regeneron Company Information
Table 96. Regeneron Description and Business Overview
Table 97. Regeneron Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Regeneron Anti-VEGF Injection Product
Table 99. Regeneron Recent Developments/Updates
Table 100. Qilu Pharmaceutical Co.,Ltd. Company Information
Table 101. Qilu Pharmaceutical Co.,Ltd. Description and Business Overview
Table 102. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Qilu Pharmaceutical Co.,Ltd. Anti-VEGF Injection Product
Table 104. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 105. Innovent Biologics Company Information
Table 106. Innovent Biologics Description and Business Overview
Table 107. Innovent Biologics Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Innovent Biologics Anti-VEGF Injection Product
Table 109. Innovent Biologics Recent Developments/Updates
Table 110. Anke Biotechnology Company Information
Table 111. Anke Biotechnology Description and Business Overview
Table 112. Anke Biotechnology Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Anke Biotechnology Anti-VEGF Injection Product
Table 114. Anke Biotechnology Recent Developments/Updates
Table 115. Shenzhen Kangzhe Pharmaceutical Co Ltd Company Information
Table 116. Shenzhen Kangzhe Pharmaceutical Co Ltd Description and Business Overview
Table 117. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Shenzhen Kangzhe Pharmaceutical Co Ltd Anti-VEGF Injection Product
Table 119. Shenzhen Kangzhe Pharmaceutical Co Ltd Recent Developments/Updates
Table 120. Chengdu Kanghong Pharmaceutical Group Company Information
Table 121. Chengdu Kanghong Pharmaceutical Group Description and Business Overview
Table 122. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Chengdu Kanghong Pharmaceutical Group Anti-VEGF Injection Product
Table 124. Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Anti-VEGF Injection Distributors List
Table 128. Anti-VEGF Injection Customers List
Table 129. Anti-VEGF Injection Market Trends
Table 130. Anti-VEGF Injection Market Drivers
Table 131. Anti-VEGF Injection Market Challenges
Table 132. Anti-VEGF Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Anti-VEGF Injection
Figure 2. Global Anti-VEGF Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-VEGF Injection Market Share by Type: 2024 & 2031
Figure 4. Ranibizumab Product Picture
Figure 5. Bevacizumab Product Picture
Figure 6. Aflibercept Product Picture
Figure 7. Brolucizumab Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anti-VEGF Injection Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Anti-VEGF Injection Market Share by Application: 2024 & 2031
Figure 11. Age-related Macular Degeneration (AMD)
Figure 12. Diabetic Retinopathy
Figure 13. Retinal Vein Occlusion (RVO)
Figure 14. Retinopathy of Prematurity (ROP)
Figure 15. Uveitis
Figure 16. Neovascular Glaucoma
Figure 17. Others
Figure 18. Global Anti-VEGF Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Anti-VEGF Injection Market Size (2020-2031) & (US$ Million)
Figure 20. Global Anti-VEGF Injection Sales (2020-2031) & (K Units)
Figure 21. Global Anti-VEGF Injection Average Price (US$/Unit) & (2020-2031)
Figure 22. Anti-VEGF Injection Report Years Considered
Figure 23. Anti-VEGF Injection Sales Share by Manufacturers in 2024
Figure 24. Global Anti-VEGF Injection Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest Anti-VEGF Injection Players: Market Share by Revenue in Anti-VEGF Injection in 2024
Figure 26. Anti-VEGF Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global Anti-VEGF Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America Anti-VEGF Injection Sales Market Share by Country (2020-2031)
Figure 29. North America Anti-VEGF Injection Revenue Market Share by Country (2020-2031)
Figure 30. United States Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe Anti-VEGF Injection Sales Market Share by Country (2020-2031)
Figure 33. Europe Anti-VEGF Injection Revenue Market Share by Country (2020-2031)
Figure 34. Germany Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific Anti-VEGF Injection Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific Anti-VEGF Injection Revenue Market Share by Region (2020-2031)
Figure 41. China Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. China Taiwan Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Anti-VEGF Injection Sales Market Share by Country (2020-2031)
Figure 49. Latin America Anti-VEGF Injection Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Anti-VEGF Injection Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Anti-VEGF Injection Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Anti-VEGF Injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Anti-VEGF Injection by Type (2020-2031)
Figure 59. Global Revenue Market Share of Anti-VEGF Injection by Type (2020-2031)
Figure 60. Global Anti-VEGF Injection Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Anti-VEGF Injection by Application (2020-2031)
Figure 62. Global Revenue Market Share of Anti-VEGF Injection by Application (2020-2031)
Figure 63. Global Anti-VEGF Injection Price (US$/Unit) by Application (2020-2031)
Figure 64. Anti-VEGF Injection Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
